思瑞浦微电子科技（苏州）股份有限公司 董事会薪酬与考核委员会 关于公司 2025 年限制性股票激励计划 激励对象名单的公示情况说明及核查意见 司"）召开了第四届董事会薪酬与考核委员会 2025 年第二次会议、第四届董事会 第四次会议，审议通过了《关于 <公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划" 草 案="草案"> 及 其摘要的议案》等相关议案。根据《上市公司股权激励管理办法》 （以下简称" 《激励计划（草案）》"） 及其摘要、 《2025 年限制性股票激励计划实施考核管理办法》及《2025 年限制性 股票激励计划激励对象名单》。 《2025 年限制性股票激励计划激励对象名单》，将本次激励计划拟授予的激励对 象的姓名及职务在公司内部予以公示，公示时间自 2025 年 5 月 31 日至 2025 年 核委员会反馈意见。 （以下简称"《管 理办法》"）的相关规定，公司对 2025 年限制性股票激励计划激励对象名单进行 了公示，公司董事会薪酬与考核委员会结合公示情况对激励对象进行了核查，相 关公示情况及核查意见如下： 一、公示情况 露了《2025 年限制性股票激励计划（草案）》 ...

Core Viewpoint - The company has approved the draft of the 2025 Restricted Stock Incentive Plan and related management measures, which are deemed to align with regulations and the company's interests, ensuring no harm to shareholders' interests [1][2][3] Group 1: Meeting Overview - The fourth supervisory board meeting was held on June 4, 2025, with all three supervisors present, and the meeting was conducted legally and effectively [1] - The meeting included the review and approval of several key proposals related to the 2025 Restricted Stock Incentive Plan [1] Group 2: Approved Proposals - The proposal regarding the draft of the 2025 Restricted Stock Incentive Plan was approved with a unanimous vote of 3 in favor, indicating it meets relevant regulations and aligns with the company's actual situation [2] - The proposal for the implementation assessment management measures of the 2025 Restricted Stock Incentive Plan was also approved unanimously, ensuring the plan's proper operation and benefiting the company's sustainable development [2] - The proposal to verify the list of incentive objects for the 2025 Restricted Stock Incentive Plan was approved, confirming that the listed individuals meet the necessary qualifications and conditions [3]

证券代码：301505 证券简称：苏州规划 公告编号：2025-040 苏州规划设计研究院股份有限公司（以下简称"公司"）第五届监事会第二 次会议通知已于 2025 年 5 月 28 日向全体监事发出并送达。本次会议于 2025 年 出席会议的监事 3 人。会议由监事会主席虞林洪召集并主持。 本次会议的召集、召开及表决程序符合《中华人民共和国公司法》（以下简 称"《公司法》"）等法律、法规、规范性文件以及《苏州规划设计研究院股份 有限公司章程》（以下简称"《公司章程》"）的有关规定，会议合法、有效。 二、监事会会议审议情况 会议审议并通过了以下议案： （一）审议通过《关于调整第一期（2025）限制性股票激励计划相关事项 的议案》 经审议，监事会认为：鉴于公司 2024 年年度权益分派已实施完毕，根据公 司《第一期（2025）限制性股票激励计划（草案）》（以下简称"《激励计划》"） 的相关规定以及 2024 年年度股东大会的授权，同意公司将限制性股票授予价格 （含预留）由 10.80 元/股调整为 8.13 元/股，将授予数量由 83.25 万股调整为 予数量由 16.65 万股调整为 21.6764 万股。本 ...

证券代码：300705 证券简称：九典制药 公告编号：2025-045 债券代码：123223 债券简称：九典转02 湖南九典制药股份有限公司 关于调整 2022 年限制性股票激励计划相关事项的公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 湖南九典制药股份有限公司（以下简称"公司"）于 2025 年 5 月 29 日召开 第四届董事会第十一次会议、第四届监事会第七次会议，审议通过了《关于调整 一、2022 年限制性股票激励计划已履行的相关审批程序 于公司<2022 年限制性股票激励计划（草案）>及其摘要的议案》 《关于公司<2022 年限制性股票激励计划实施考核管理办法>的议案》等议案。公司独立董事就本 激励计划相关议案发表了独立意见。 于公司<2022 年限制性股票激励计划（草案）>及其摘要的议案》 《关于公司<2022 年限制性股票激励计划实施考核管理办法>的议案》以及《关于公司<2022 年限 制性股票激励计划授予激励对象名单>的议案》，公司监事会对本激励计划的事 项进行核实并出具了相关核查意见。 象的姓名和职务在公司官网进行了公示。在公示期内， ...

湖南启元律师事务所 关于湖南九典制药股份有限公司 调整相关事项、作废部分限制性股票及第三个归属 期归属条件成就的 法律意见书 ·湖南启元律师事务所· HUNAN QIYUAN LAW FIRM 湖南省长沙市芙蓉区建湘路 393 号世茂环球金融中心 63 层 410000 电话：0731-82953778 传真：0731-82953779 网站：www.qiyuan.com 致：湖南九典制药股份有限公司 湖南启元律师事务所（以下简称"本所"）接受湖南九典制药股份有限公司（以 下简称 "九典制药"、"公司"）的委托，作为公司2022年限制性股票激励计划（以 下简称"本次激励计划"）的专项法律顾问，根据《中华人民共和国公司法》（以 下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《深圳证券交 易所创业板股票上市规则（2025年修订）》（以下简称"《上市规则》"）等有 关法律、法规、规章及规范性文件的规定，就公司本次激励计划授予价格调整（以 下简称"本次调整"）、作废部分限制性股票（以下简称"本次作废"）及第三 个归属期归属条件成 ...

证券代码：688050 证券简称：爱博医疗 公告编号：2025-029 爱博诺德（北京）医疗科技股份有限公司 第二届监事会第十六次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 爱博诺德（北京）医疗科技股份有限公司（以下简称"公司"）第二届监事 会第十六次会议通知及相关材料于 2025 年 5 月 23 日以电子邮件的方式发出。会 议于 2025 年 5 月 29 日在公司会议室以现场与通讯相结合方式召开，本次会议由 监事会主席王丹璇女士召集并主持，应出席的监事 3 人，实际出席的监事 3 人。 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法律、法规、 规章、规范性文件和《公司章程》等有关规定，会议形成的决议合法、有效。经 与会监事认真讨论，审议通过如下事项： 一、审议并通过《关于 2024 年年度利润分配方案的议案》 经与会监事认真审议，监事会认为：公司 2024 年年度利润分配方案充分考虑 了公司盈利情况、现金流状态及资金需求计划，结合了当前发展阶段、长远发展 规则及股东合理回报规划等各种 ...

Core Viewpoint - The company has announced adjustments to its 2021 restricted stock incentive plan, including the cancellation of certain restricted stocks due to the departure of an incentive object and the adjustment of the grant price based on profit distribution plans [1][2][8]. Summary by Sections 1. Decision Process and Disclosure - The company held meetings to review and approve the 2021 restricted stock incentive plan, ensuring compliance with legal and regulatory requirements, and independent directors provided opinions on the plan's benefits [2][4][5]. 2. Adjustments and Results - The company adjusted the grant price of the restricted stocks from 67.63 yuan to 66.65 yuan per share due to profit distribution, which included a cash dividend of 2.3 yuan per 10 shares for the first half of 2024 and 7.50 yuan per 10 shares for the entire year [6][7][8]. 3. Cancellation of Restricted Stocks - A total of 18,136 shares of restricted stock were canceled due to one incentive object leaving the company and another object voluntarily waiving their rights to the stocks [8][9]. 4. Impact on Company - The adjustments to the grant price and the cancellation of restricted stocks are not expected to materially affect the company's financial status or operational results, nor will they impact the stability of the core team or the continuation of the equity incentive plan [8][9]. 5. Supervisory Board Opinion - The supervisory board confirmed that the adjustments and cancellations comply with relevant laws and regulations, and they do not harm the interests of the company or its shareholders [9].

Core Viewpoint - The company has adjusted its 2025 Restricted Stock Incentive Plan, including changes to the list of incentive targets, the number of shares granted, and the grant price, following the authorization from the 2024 annual general meeting [1][5]. Summary by Sections Approval Process - The incentive plan was approved and submitted for board review, including various related proposals [1][2]. Reasons for Adjustment and Results - Two out of 54 incentive targets voluntarily waived a total of 70,000 shares, leading to adjustments in the number of targets and shares granted. The number of incentive targets has been modified accordingly [2][5]. - The 2024 annual equity distribution was completed on May 26, 2025, with a cash dividend of 3.50 yuan per 10 shares, totaling 63 million yuan [2]. Grant Price Adjustment - The grant price for the restricted stock was adjusted from 8.27 yuan to 7.92 yuan per share after accounting for the cash dividend [4]. Impact on the Company - The adjustments comply with relevant laws and regulations, ensuring no harm to the company or its shareholders, and will not materially affect the company's financial status or operating results [5]. Supervisory Board Opinion - The supervisory board confirmed that the adjustments align with legal regulations and do not harm shareholder interests, thus approving the changes [5]. Compensation and Assessment Committee Opinion - The compensation and assessment committee also found the adjustments compliant with regulations and beneficial to shareholders, thus agreeing to the changes [5]. Legal Opinion - The legal counsel confirmed that the adjustments have received necessary approvals and comply with relevant regulations [5].

Group 1 - The company held its 14th meeting of the third board of directors on May 26, 2025, where all 7 directors attended, and the meeting was deemed legal and effective [1][2]. - The board approved the achievement of the vesting conditions for the second vesting period of the 2023 restricted stock incentive plan, allowing 1,213,530 shares to vest for 244 eligible participants [1][20][54]. - The board also approved the cancellation of certain unvested restricted stocks due to participants leaving the company and performance issues, totaling 119,430 shares [4][68][71]. Group 2 - The company plans to extend the validity period of the shareholder meeting resolution for issuing convertible bonds to June 12, 2026, to ensure the smooth progress of the issuance [7][8][23]. - The board proposed to hold the second extraordinary general meeting of shareholders on June 11, 2025, combining on-site and online voting [17][18]. Group 3 - The company nominated Li Xuesheng as a candidate for independent director to replace Wang Zheyao, who resigned, pending approval at the upcoming shareholder meeting [12][14][15]. - The board approved the adjustment of the committee members of the board to ensure the orderly operation of the committees following the resignation [15][16].

上海派能能源科技股份有限公司 董事会薪酬与考核委员会关于2025年限制性股票激励 （本页无正文，为《上海派能能源科技股份有限公司董事会薪酬与考核委员会关 于2025 年限制性股票激励计划首次授予激励对象名单的核查意见》签字页） 薪酬与考核委员会委员签字： 二、本计划首次授予激励对象不包括独立董事、监事、外籍员工、单独或合 计持有上市公司 5%以上股份的股东、上市公司实际控制人及其配偶、父母、子女。 三、除 3 名激励对象因离职失去激励对象资格外，公司本次激励计划首次授 予部分激励对象名单与公司 2024 年年度股东大会批准的《2025 年限制性股票 激励计划（草案）》中规定的激励对象相符。 四、本次激励计划首次授予部分激励对象名单符合《公司法》《证券法》等 法律、法规和规范性文件以及《公司章程》规定的任职资格，符合《上市公司股 权激励管理办法》《上海证券交易所科创板股票上市规则》等法律、法规和规范 性文件规定的激励对象条件，符合公司《2025 年限制性股票激励计划（草案）》 规定的激励对象条件。 综上所述，董事会薪酬与考核委员会同意公司本次激励计划首次授予的激励 对象名单，同意公司以 2025 年 5 月 2 ...